CDH2 and metastatic prostate carcinoma: We also discovered that ADAM15 expression in metastatic prostate cancer correlated with elevated levels of sE-cad found in the serum of these patients [57,58] and demonstrated that ADAM15 did indeed cleave E-cadherin and N-cadherin in tumor cells [19,21–23].